{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:01:52Z","timestamp":1792141312972,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.ygyno.2005.08.038","type":"journal-article","created":{"date-parts":[[2005,9,27]],"date-time":"2005-09-27T14:19:16Z","timestamp":1127830756000},"page":"20-26","source":"Crossref","is-referenced-by-count":148,"title":["CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer"],"prefix":"10.1016","volume":"100","author":[{"given":"R.I.","family":"Olivier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.C.","family":"Lubsen-Brandsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van Beurden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2005.08.038_bib1","series-title":"Trends of cancer in The Netherlands 1989\u20131998","author":"Van Dijck","year":"2002"},{"key":"10.1016\/j.ygyno.2005.08.038_bib2","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1471-0528.1998.tb09966.x","article-title":"The performance of screening tests for ovarian cancer: results of a systematic review","volume":"105","author":"Bell","year":"1998","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib3","first-page":"14","article-title":"Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer","volume":"80","author":"Einhorn","year":"1992","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.313.7069.1355","article-title":"Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study","volume":"313","author":"Jacobs","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2005.08.038_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1006\/gyno.2000.5816","article-title":"The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer","volume":"77","author":"van Nagell","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0301-2115(95)02369-0","article-title":"A combined approach for the early detection of ovarian cancer in asymptomatic women","volume":"65","author":"Adonakis","year":"1996","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib7","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/bmj.306.6884.1030","article-title":"Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography","volume":"306","author":"Jacobs","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2005.08.038_bib8","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/sj.bjc.6690575","article-title":"Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation","volume":"80","author":"Menon","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2005.08.038_bib9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(98)10261-1","article-title":"Screening for ovarian cancer: a pilot randomised controlled trial","volume":"353","author":"Jacobs","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2005.08.038_bib10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2005.08.038_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/gyno.1994.1065","article-title":"The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer","volume":"52","author":"Bourne","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/j.1600-0412.1999.781013.x","article-title":"Prospectively detected cancer in familial breast\/ovarian cancer screening","volume":"78","author":"Dorum","year":"1999","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2005.08.038_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0002-9378(93)90607-K","article-title":"A multidisciplinary approach to the early detection of ovarian carcinoma: rationale, protocol design, and early results","volume":"169","author":"Karlan","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1525-1438.2002.01055.x","article-title":"Use of CA-125 and ultrasound in high-risk women","volume":"12","author":"Laframboise","year":"2002","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2005.08.038_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/gyno.1993.1239","article-title":"Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center","volume":"51","author":"Muto","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0959-8049(96)00137-2","article-title":"Early detection of familial ovarian cancer","volume":"32A","author":"Dorum","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2005.08.038_bib17","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.20.5.1260","article-title":"Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers","volume":"20","author":"Scheuer","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.277.12.997","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2, Cancer Genetics Studies Consortium","volume":"277","author":"Burke","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2005.08.038_bib19","first-page":"70","article-title":"Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy","volume":"78","author":"Sassone","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1200\/JCO.2004.07.179","article-title":"Biology of epithelial ovarian cancer: implications for screening women at high genetic risk","volume":"22","author":"Hogg","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0090-8258(91)90051-6","article-title":"Ultrasound screening for familial ovarian cancer","volume":"43","author":"Bourne","year":"1991","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib22","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1200\/JCO.2003.01.088","article-title":"Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1\/BRCA2 mutation testing","volume":"21","author":"Schwartz","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib23","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up","volume":"90","author":"Olivier","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2005.08.038_bib24","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.20.6.1570","article-title":"Cancer incidence in a population of Jewish women at risk of ovarian cancer","volume":"20","author":"Liede","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/172460089801300411","article-title":"CA 125 in benign gynecological conditions","volume":"13","author":"Meden","year":"1998","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.ygyno.2005.08.038_bib26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/humrep\/14.2.566","article-title":"Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles","volume":"14","author":"Bon","year":"1999","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ygyno.2005.08.038_bib27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0029-7844(03)00670-7","article-title":"Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter","volume":"102","author":"Modesitt","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.08.038_bib28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/mcp.R400006-MCP200","article-title":"Progress and challenges in screening for early detection of ovarian cancer","volume":"3","author":"Jacobs","year":"2004","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ygyno.2005.08.038_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.280.8.719","article-title":"Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers","volume":"280","author":"Xu","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2005.08.038_bib30","doi-asserted-by":"crossref","first-page":"12343","DOI":"10.1073\/pnas.2033602100","article-title":"Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis","volume":"100","author":"Kozak","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2005.08.038_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","article-title":"Use of proteomic patterns in serum to identify ovarian cancer","volume":"359","author":"Petricoin","year":"2002","journal-title":"Lancet"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805007675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805007675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T07:21:04Z","timestamp":1553584864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825805007675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0090825805007675"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2005.08.038","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}